v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (5,661) $ (31,382)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization expense 1,180 1,153
Provision for bad debts and product returns 700 2,439
Investor fee 916 0
Change in fair value of warrant liability (18,867) (2,523)
Provision for inventory write-downs 3,804 4,367
Insurance proceeds related to operating activities 0 (1,993)
Income taxes payable 0 (13,326)
Stock-based compensation 2,299 2,349
Asset impairment and abandonments 1,935 4,382
Gain on acquisition contingency (10,493) (2,287)
Loss on sale of discontinued operations 0 6,316
Bargain purchase gain 0 (90)
Other (3) (33)
Change in assets and liabilities:    
Accounts receivable (2,082) (3,777)
Inventories (4,767) (9,111)
Accounts payable 446 (3,818)
Accrued expenses (7,025) 23,605
Right-of-use asset and lease liability 223 (3,165)
Other operating assets and liabilities 4,986 (19,253)
Net cash used in operating activities (32,409) (46,147)
Cash flows from investing activities:    
Payments for OEM working capital adjustment 0 (5,430)
Purchases of property and equipment (3,034) (4,952)
Business acquisitions, net of cash acquired 0 (330)
Patent and acquired intangible asset costs (184) (311)
Net cash used in investing activities (3,218) (11,023)
Cash flows from financing activities:    
Share offering proceeds including prefunded warrant exercised, net 17,729 82,326
Proceeds from exercise of common stock options 0 23
Proceeds from Employee Stock Purchase Program (ESPP) 186 0
Payment of Holo Milestones - contingent consideration (4,081) 0
Payments for treasury stock (56) (133)
Net cash provided by financing activities 13,778 82,216
Effect of exchange rate changes on cash and cash equivalents (94) 249
Net (decrease) increase in cash and cash equivalents (21,943) 25,295
Cash and cash equivalents, beginning of period 51,287 43,962
Cash and cash equivalents, end of period 29,344 69,257
Supplemental cash flow disclosure:    
Net income tax payments, net of refunds 1,548 15,481
Non-cash acquisition of property and equipment 189 629
Prompt    
Non-cash common stock issuance 0 221
Holo Surgical Inc    
Non-cash common stock issuance $ 5,919 $ 0

Source